Antibiotics | Total No. of resistant E. coli isolates(N = 36) | Total No. of resistant K. pneumoniae isolates(N = 74) |
---|---|---|
Ampicillin (AMP) | 36 (100%) | 74 (100%) |
Ampicillin/Sulbactam (AMA) | 23 (63.89) | 64 (86.49%) |
Piperacillin/Tazobactam (TZP) | 6 (16.67%) | 52 (70.27%) |
Cefazolin (CZ) | 36 (100%) | 74 (100%) |
Cefoxitin (FOX) | 20 (55.56%) | 51(68.92%) |
Ceftazidime (CAZ) | 36 (100%) | 73 (98.65%) |
Ceftriaxone (CRO) | 36 (100%) | 74 (100%) |
Cefepime (FEP) | 33 (91.67%) | 73 (98.65%) |
Meropenem (MEM) | 3 (8.33%) | 47 (63.51%) |
Ertapenem (ERT) | 3 (8.33%) | 52 (70.72%) |
Amikacin (AMK) | 2 (5.56%) | 41 (55.41%) |
Gentamicin (GN) | 15 (41.67%) | 45 (60.81%) |
Tobramycin (TOB) | 12 (33.33) | 50 (67.57%) |
Ciprofloxacin (CIP) | 28 (77.78%) | 56 (75.68%) |
Levofloxacin (LVX) | 29 (80.56%) | 56 (75.68%) |
Nitrofurantoin (NIF) | 3 (8.33%) | 52 (70.27%) |
Sulfamethoxazole/trimethoprim (SXT) | 20 (55.56%) | 67 (90.54%) |
Tigecycline (TGI) | 1 (2.78%) | 10 (13.51%) |